Spyre Therapeutics
SYRE
SYRE
68 hedge funds and large institutions have $158M invested in Spyre Therapeutics in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 71 → 68 (-3)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Holders
68
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$764K | |
| 2 | +$432K | |
| 3 | +$392K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$389K |
| 5 |
Two Sigma Investments
New York
|
+$379K |
Top Sellers
| 1 | -$3.85M | |
| 2 | -$375K | |
| 3 | -$192K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$180K |
| 5 |
Squarepoint
New York
|
-$173K |